MYOM3

gene
On this page

Also known as FLJ35961

Summary

MYOM3 (myomesin 3, HGNC:26679) is a protein-coding gene on chromosome 1p36.11, encoding Myomesin-3 (Q5VTT5). May link the intermediate filament cytoskeleton to the M-disk of the myofibrils in striated muscle.

Predicted to enable protein homodimerization activity. Predicted to be involved in sarcomere organization. Predicted to be located in cytoplasm. Predicted to be active in M band.

Source: NCBI Gene 127294 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 306 total
  • MANE Select transcript: NM_152372

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26679
Approved symbolMYOM3
Namemyomesin 3
Location1p36.11
Locus typegene with protein product
StatusApproved
AliasesFLJ35961
Ensembl geneENSG00000142661
Ensembl biotypeprotein_coding
OMIM616832
Entrez127294

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 7 protein_coding, 2 protein_coding_CDS_not_defined

ENST00000338909, ENST00000374434, ENST00000448831, ENST00000475306, ENST00000958996, ENST00000958997, ENST00000958998, ENST00000958999, ENST00000959000

RefSeq mRNA: 1 — MANE Select: NM_152372 NM_152372

CCDS: CCDS41281

Canonical transcript exons

ENST00000374434 — 37 exons

ExonStartEnd
ENSE000010364912407615924076273
ENSE000010365282408133024081456
ENSE000010365572408001624080194
ENSE000010366032406822324068367
ENSE000010366242407531924075475
ENSE000011301972406797024068029
ENSE000012093362407416024074269
ENSE000012093692408446824084639
ENSE000012698472407196924072013
ENSE000012698842408259324082714
ENSE000012985292406702124067088
ENSE000013059432407111724071253
ENSE000013086042406194624062109
ENSE000013114442406407224064159
ENSE000013139382405892424058979
ENSE000013224632406349224063530
ENSE000013259152406312624063234
ENSE000013917252408200124082188
ENSE000014061572411203124112135
ENSE000014635172406106024061082
ENSE000014635212406127324061309
ENSE000014635232406589124066001
ENSE000017106312410799324108073
ENSE000018846852405604124057627
ENSE000023196062410847624108654
ENSE000034910442409294724093108
ENSE000035059552408664424086827
ENSE000035100522410707324107232
ENSE000035126642409792324098011
ENSE000035185902408953824089665
ENSE000035188462409217424092315
ENSE000035350502409544224095486
ENSE000035917112409006524090118
ENSE000036052462409485324094990
ENSE000036222522410592024106077
ENSE000036300872409079724090996
ENSE000036414702409968024099775

Expression profiles

Bgee: expression breadth ubiquitous, 175 present calls, max score 98.49.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 2.1111 / max 336.9549, expressed in 111 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
110331.865478
110340.126930
110320.066127
2014090.041623
110310.01107

Top tissues by expression

249 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
apex of heartUBERON:000209898.49gold quality
hindlimb stylopod muscleUBERON:000425298.29gold quality
gastrocnemiusUBERON:000138897.56gold quality
heart left ventricleUBERON:000208497.43gold quality
left ventricle myocardiumUBERON:000656697.30gold quality
cardiac ventricleUBERON:000208297.20gold quality
right atrium auricular regionUBERON:000663197.16gold quality
cardiac muscle of right atriumUBERON:000337997.12gold quality
cardiac atriumUBERON:000208196.91gold quality
tibialis anteriorUBERON:000138596.65gold quality
muscle of legUBERON:000138396.13gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451195.61gold quality
skeletal muscle tissueUBERON:000113494.12gold quality
heart right ventricleUBERON:000208093.47gold quality
vastus lateralisUBERON:000137992.32gold quality
quadriceps femorisUBERON:000137792.19gold quality
heartUBERON:000094891.82gold quality
myocardiumUBERON:000234991.77gold quality
deltoidUBERON:000147691.43silver quality
biceps brachiiUBERON:000150790.89gold quality
muscle tissueUBERON:000238590.57gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450289.76gold quality
body of tongueUBERON:001187687.27gold quality
pancreatic ductal cellCL:000207986.01silver quality
adult mammalian kidneyUBERON:000008283.85gold quality
buccal mucosa cellCL:000233682.57gold quality
kidney epitheliumUBERON:000481981.40silver quality
kidneyUBERON:000211380.19gold quality
tongueUBERON:000172379.51gold quality
upper arm skinUBERON:000426377.78gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.67

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

44 targeting MYOM3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4713-3P100.0065.92505
HSA-MIR-4425100.0067.591049
HSA-MIR-150-5P99.9966.691976
HSA-MIR-477599.9875.006394
HSA-MIR-7152-3P99.9767.47849
HSA-MIR-590-3P99.9674.346478
HSA-MIR-426799.9666.532368
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-6753-3P99.9366.57637
HSA-MIR-7107-3P99.9366.73627
HSA-MIR-3529-3P99.9073.553045
HSA-MIR-1343-3P99.8966.781815
HSA-MIR-629-3P99.8567.991875
HSA-MIR-4713-5P99.7867.801794
HSA-MIR-1273H-5P99.7766.322471
HSA-MIR-30B-3P99.7065.762325
HSA-MIR-3689A-3P99.7065.732306
HSA-MIR-3689B-3P99.7065.712311
HSA-MIR-3689C99.7065.712311
HSA-MIR-6779-5P99.7065.762363
HSA-MIR-613299.6065.831554
HSA-MIR-6836-5P99.6065.621538
HSA-MIR-671-5P99.5267.111277
HSA-MIR-1207-5P99.4969.112983
HSA-MIR-4735-5P99.4368.491780
HSA-MIR-532-3P99.3465.761195
HSA-MIR-425499.1165.151315
HSA-MIR-328-5P99.0864.651000
HSA-MIR-6885-5P98.7164.33902
HSA-MIR-4725-5P98.6765.42628

Literature-anchored findings (GeneRIF, showing 3)

  • MYOM3 fragments hold promise for minimally invasive assessment of experimental therapies for DMD and other neuromuscular disorders. (PMID:26060189)
  • mutations in Pakistani patients with dilated cardiomyopathy rs375563861 (C2orf40), rs143187236 (MYOM3), and rs564181443 (RTKN2) have 3 fold or higher allele frequency in South Asians than in the global populations (PMID:29886034)
  • An acute eccentric exercise increases circulating myomesin 3 fragments. (PMID:33468054)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusMyom3ENSMUSG00000037139
rattus_norvegicusMyom3ENSRNOG00000032994
drosophila_melanogastermtgoFBGN0259735
caenorhabditis_elegansWBGENE00007944

Paralogs (11): MYOM2 (ENSG00000036448), FNDC3B (ENSG00000075420), MYBPC2 (ENSG00000086967), MYOM1 (ENSG00000101605), FNDC3A (ENSG00000102531), OBSL1 (ENSG00000124006), MYBPH (ENSG00000133055), MYBPC3 (ENSG00000134571), IGSF22 (ENSG00000179057), MYBPC1 (ENSG00000196091), MYBPHL (ENSG00000221986)

Protein

Protein identifiers

Myomesin-3Q5VTT5 (reviewed: Q5VTT5)

Alternative names: Myomesin family member 3

All UniProt accessions (1): Q5VTT5

UniProt curated annotations — full annotation on UniProt →

Function. May link the intermediate filament cytoskeleton to the M-disk of the myofibrils in striated muscle.

Subunit / interactions. Homodimer.

Subcellular location. Cytoplasm. Myofibril. Sarcomere. M line.

Isoforms (3)

UniProt IDNamesCanonical?
Q5VTT5-11yes
Q5VTT5-22
Q5VTT5-33

RefSeq proteins (1): NP_689585* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003598Ig_sub2Domain
IPR003599Ig_subDomain
IPR003961FN3_domDomain
IPR007110Ig-like_domDomain
IPR013098Ig_I-setDomain
IPR013783Ig-like_foldHomologous_superfamily
IPR036116FN3_sfHomologous_superfamily
IPR036179Ig-like_dom_sfHomologous_superfamily
IPR050964Striated_Muscle_RegulatoryFamily

Pfam: PF00041, PF07679

UniProt features (34 total): sequence variant 12, domain 9, sequence conflict 5, splice variant 4, chain 1, region of interest 1, coiled-coil region 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5VTT5-F176.550.19

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 69 (showing top): GCANCTGNY_MYOD_Q6, GOBP_STRIATED_MUSCLE_CELL_DIFFERENTIATION, TGACCTY_ERR1_Q2, GOBP_SARCOMERE_ORGANIZATION, GOBP_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS, GOBP_MUSCLE_STRUCTURE_DEVELOPMENT, GOBP_ACTOMYOSIN_STRUCTURE_ORGANIZATION, GRE_C, GOBP_ORGANELLE_ASSEMBLY, GOMF_STRUCTURAL_CONSTITUENT_OF_MUSCLE, E12_Q6, GOBP_MUSCLE_CELL_DEVELOPMENT, TGACCTTG_SF1_Q6, GOBP_MUSCLE_CELL_DIFFERENTIATION, GOCC_M_BAND

GO Biological Process (1): sarcomere organization (GO:0045214)

GO Molecular Function (3): protein homodimerization activity (GO:0042803), protein binding (GO:0005515), identical protein binding (GO:0042802)

GO Cellular Component (2): M band (GO:0031430), cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
myofibril assembly1
actomyosin structure organization1
identical protein binding1
protein dimerization activity1
binding1
protein binding1
A band1
intracellular anatomical structure1

Protein interactions and networks

STRING

742 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MYOM3SGCAQ16586552
MYOM3MYOZ2Q9NPC6538
MYOM3TNNI1P19237515
MYOM3COX6A2Q02221472
MYOM3MYOM2P54296434
MYOM3MYL1P05976431
MYOM3LRRC39Q96DD0427
MYOM3ANKRD2Q9GZV1425
MYOM3CSRP3P50461425
MYOM3TNNT3P45378421
MYOM3MYH7P12883418
MYOM3TNNI2P48788413
MYOM3MYL3P08590410
MYOM3TNNT1P13805393
MYOM3CKMT2P17540389

IntAct

6 interactions, top by confidence:

ABTypeScore
Ppsi-mi:“MI:0914”(association)0.350
MRPS23MYH7Bpsi-mi:“MI:0914”(association)0.350
CSNK2BTUBAL3psi-mi:“MI:0914”(association)0.350
AMOTMYOM3psi-mi:“MI:0915”(physical association)0.000
MYOM3ASH2Lpsi-mi:“MI:0915”(physical association)0.000

BioGRID (10): MYOM3 (Affinity Capture-MS), MYOM3 (Affinity Capture-MS), MYOM3 (Two-hybrid), MYOM3 (Two-hybrid), MYOM3 (Two-hybrid), MYOM3 (Two-hybrid), MYOM3 (Two-hybrid), MYOM3 (Two-hybrid), MYOM3 (Affinity Capture-RNA), SPG21 (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A0A087WV53, A1CS92, A2ABU4, A2Q908, A2RUH7, A4QZL9, D3ZHA0, O01761, O70468, O75369, O88599, P05548, P11275, P11730, P11798, P13466, P21333, P56276, P56741, P70402, P79280, Q05623, Q13177, Q13203, Q13557, Q14315, Q2GM53, Q2HJF7, Q2URB7, Q5FW53, Q5PQM4, Q5RCC4, Q5VTT5, Q5ZJJ9, Q5ZKI0, Q62422, Q63518, Q6C1H8, Q6P686, Q6PHZ2

Diamond homologs: A0JN74, A1L4K1, A2ABU4, A2ASS6, B1H278, H0UZ81, O00478, P18892, P82456, Q02084, Q13410, Q1XHU0, Q495X7, Q5BN31, Q5D7I0, Q5R7W8, Q5R996, Q5VTT5, Q6MFZ5, Q6UX41, Q6UXE8, Q70KF4, Q7YRV4, Q8BVW3, Q8BZ52, Q8N3K9, Q8VI40, Q8WVV5, Q8WZ42, Q91431, Q96F44, Q96KV6, Q96PL5, Q99PQ2, Q9ESN2, Q9HCM9, Q9JLN5, A2AAJ9, O88599, P12960

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

306 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance259
Likely benign17
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

4663 predictions. Top by Δscore:

VariantEffectΔscore
1:24057628:C:CCacceptor_gain1.0000
1:24057632:T:TCacceptor_gain1.0000
1:24058928:T:Cdonor_gain1.0000
1:24061058:A:ACdonor_gain1.0000
1:24061059:C:CCdonor_gain1.0000
1:24061940:GCTCA:Gdonor_loss1.0000
1:24061941:CTCAC:Cdonor_loss1.0000
1:24061942:TCA:Tdonor_loss1.0000
1:24061943:CACCT:Cdonor_loss1.0000
1:24061944:A:AGdonor_loss1.0000
1:24061981:T:TAdonor_gain1.0000
1:24061986:C:Adonor_gain1.0000
1:24062105:TGTCT:Tacceptor_gain1.0000
1:24062106:GTCT:Gacceptor_gain1.0000
1:24062108:CT:Cacceptor_gain1.0000
1:24062109:TC:Tacceptor_loss1.0000
1:24062110:C:CCacceptor_gain1.0000
1:24062110:C:CGacceptor_loss1.0000
1:24062111:T:Aacceptor_loss1.0000
1:24062114:A:ACacceptor_gain1.0000
1:24062114:A:Cacceptor_gain1.0000
1:24062116:G:Cacceptor_gain1.0000
1:24062116:G:GCacceptor_gain1.0000
1:24063122:TTAC:Tdonor_loss1.0000
1:24063123:TACTT:Tdonor_loss1.0000
1:24063124:A:ACdonor_gain1.0000
1:24063124:A:Tdonor_loss1.0000
1:24063125:C:CAdonor_gain1.0000
1:24063125:CT:Cdonor_gain1.0000
1:24063125:CTT:Cdonor_gain1.0000

AlphaMissense

9347 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:24057445:G:CN1411K0.999
1:24057445:G:TN1411K0.999
1:24076239:A:GF874S0.999
1:24080089:A:TV838D0.999
1:24080136:C:AW822C0.999
1:24080136:C:GW822C0.999
1:24080138:A:GW822R0.999
1:24080138:A:TW822R0.999
1:24081422:A:GF772S0.999
1:24082123:A:GW720R0.999
1:24082123:A:TW720R0.999
1:24082673:A:GF671S0.999
1:24086724:A:GF573S0.999
1:24097986:A:CY228D0.999
1:24057446:T:AN1411I0.998
1:24057452:A:TV1409D0.998
1:24062047:A:GL1278P0.998
1:24064135:A:CY1187D0.998
1:24074223:A:CY969D0.998
1:24075383:A:GW932R0.998
1:24075383:A:TW932R0.998
1:24076220:A:CN880K0.998
1:24076220:A:TN880K0.998
1:24080096:A:CY836D0.998
1:24080137:C:GW822S0.998
1:24080143:A:GL820P0.998
1:24082121:C:AW720C0.998
1:24082121:C:GW720C0.998
1:24082122:C:GW720S0.998
1:24082667:A:TV673D0.998

dbSNP variants (sampled 300 via entrez): RS1000022567 (1:24113097 G>A), RS1000031554 (1:24100729 A>G), RS1000120884 (1:24103222 C>T), RS1000215079 (1:24100909 A>G), RS1000272353 (1:24110523 C>T), RS1000306072 (1:24074343 G>A,T), RS1000329295 (1:24089849 T>C), RS1000425134 (1:24089856 A>G,T), RS1000485345 (1:24068745 G>A), RS1000498740 (1:24102191 C>T), RS1000514799 (1:24086568 G>C), RS1000606847 (1:24068545 T>C), RS1000612066 (1:24096399 C>T), RS1000612690 (1:24058175 G>A), RS1000775880 (1:24100543 C>G)

Disease associations

OMIM: gene MIM:616832 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST001715_10Bipolar disorder with mood-incongruent psychosis4.000000e-06
GCST006098_9Vigorous physical activity5.000000e-09
GCST007576_232Chronotype3.000000e-08

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0008002physical activity measurement
EFO:0008328chronotype measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

24 total (human), top 24 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation2
aristolochic acid Iincreases expression1
propionaldehydeincreases expression1
bisphenol Adecreases methylation1
tris(2-butoxyethyl) phosphateaffects expression1
butyraldehydedecreases expression1
CGP 52608affects binding, increases reaction1
abrinedecreases expression1
incobotulinumtoxinAdecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Temozolomidedecreases expression1
Sunitinibdecreases expression1
Leflunomidedecreases expression1
Arsenicdecreases expression1
Copperdecreases expression, affects cotreatment1
Doxorubicindecreases expression1
Estradiolaffects cotreatment, increases expression1
Folic Aciddecreases expression1
Niclosamideincreases expression1
Rotenonedecreases expression1
Silicon Dioxideincreases expression1
Urethanedecreases expression1
Valproic Acidincreases methylation1
Okadaic Acidincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.